Jim Cramer's top 10 things to watch in the stock market Tuesday

AI enthusiasm pushed the Nasdaq to its first record close since June, while the S&P 500 moved within 1% of its own record; futures indicated a steady follow-through open. AMD surged nearly 10% to join the $1 trillion market-cap club, while Meta's price target was raised to $875 from $710 and Microsoft's to $570 from $515 on accelerating AI-product demand. Crude oil extended declines to a fifth session on hopes for a full Strait of Hormuz reopening, supporting bond prices and lower yields. Separately, Roche's obesity drug candidate produced 15.5% weight loss at 48 weeks in a phase 2 trial, though commercialization remains years away.

Analysis

The AI move is broadening from GPU scarcity into the CPU/control-plane layer, but AMD and INTC now carry materially different execution risk. AMD’s valuation requires sustained data-center share gains and credible software adoption; INTC’s rally is more vulnerable because foundry losses, capex intensity, and customer commitments—not agentic-AI enthusiasm—determine equity value. META and MSFT have cleaner near-term monetization paths: a consumer agent can improve engagement and ad targeting at META, while Copilot/ Azure attach rates convert enterprise AI demand into recurring revenue at MSFT. Over the next 1-3 months, the key falsifier is not further price-target action but disclosed inference revenue, Copilot paid-seat growth, and AI capex commentary that does not outrun monetization.

Lower crude and falling yields create opposing sector effects: refiners lose feedstock-dislocation and inventory-tailwind support, while lower rates can help regional-bank securities marks and loan demand. VLO/MPC have already enjoyed an unusually favorable refining cycle; if crude weakness reflects normalized Hormuz flows rather than demand deterioration, crack spreads—not crude direction—will determine whether downgrades become an earnings problem. For KEY and FITB, the next earnings cycle is a tradable catalyst only if deposit beta, NII guidance, and criticized-loan trends improve simultaneously; lower Treasury yields alone can compress asset yields faster than funding costs.

Roche’s obesity data is strategically relevant but not yet a near-term threat to LLY: the investable issue is whether future supply expansion and oral/incretin competition shift LLY from supply-constrained growth to price competition in 2027-28. ONON’s long-range growth target likely requires higher demand creation and distribution spend, making gross-margin durability more important than topline ambition in a promotional athletic-footwear market.

Key Decisions for Investors

• Prefer long MSFT / short AMD as a 3-6 month AI monetization pair: MSFT has recurring enterprise distribution and capital-return support, while AMD is more exposed to multiple compression if accelerator/CPU revenue guidance disappoints. Exit if AMD raises full-year data-center outlook materially or MSFT reports decelerating Azure growth.
• Do not chase INTC after the sharp move; establish a 1-3 month downside watch via put spreads only if the stock fails to hold its post-offering support level. The catalyst is foundry margin/capex guidance, and the thesis is invalidated by a funded external-foundry customer win with binding volume commitments.
• Maintain underweight VLO and MPC versus XLE for the next quarter; use any crack-spread rebound to add. Cover if Gulf Coast crack spreads re-expand decisively or refinery outages tighten product balances, as these matter more than headline oil weakness.
• Watch KEY and FITB into earnings rather than buying on analyst actions. Initiate only if management guides to stable-to-improving NII while deposit costs decline and commercial-credit provisioning remains contained; otherwise lower yields are a margin risk, not a catalyst.
• Remain long LLY on a 6-18 month horizon, but avoid extrapolating competitor phase-2 data into near-term share loss. Reduce if obesity prescription growth slows despite expanded supply or if management signals material realized-net-price pressure.